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We have studied the largely unknown genetic underpinnings of height growth by using a unique resource of longitudinal childhood
height data available in Finnish population cohorts. After applying GWAS mapping of potential genes inﬂuencing pubertal height
growth followed by further characterization of the genetic effects on complete postnatal growth trajectories, we have identiﬁed strong
association between variants near LIN28B and pubertal growth (rs7759938; female p ¼ 4.0 3 109, male p ¼ 1.5 3 104, combined
p ¼ 5.0 3 1011, n ¼ 5038). Analysis of growth during early puberty conﬁrmed an effect on the timing of the growth spurt. Correlated
SNPs have previously been implicated as inﬂuencing both adult stature and age at menarche, the same alleles associating with taller
height and later age of menarche in other studies as with later pubertal growth here. Additionally, a partially correlated LIN28B SNP,
rs314277, has been associated previously with ﬁnal height. Testing both rs7759938 and rs314277 (pairwise r2 ¼ 0.29) for independent
effects on postnatal growth in 8903 subjects indicated that the pubertal timing-associated marker rs7759938 affects prepubertal growth
in females (p ¼ 7 3 105) and ﬁnal height in males (p ¼ 5 3 104), whereas rs314277 has sex-speciﬁc effects on growth (p for
interaction ¼ 0.005) that were distinct from those observed at rs7759938. In conclusion, partially correlated variants at LIN28B tag
distinctive, complex, and sex-speciﬁc height-growth-regulating effects, inﬂuencing the entire period of postnatal growth. These ﬁndings
imply a critical role for LIN28B in the regulation of human growth.Human growth in height is a multifaceted process
including periods of accelerated and decelerated growth
velocities. The postnatal growth trajectory can be concep-
tualized as consisting of three partially overlapping phases
of growth: infant growth characterized by rapidly
declining growth velocities, slowly decelerating childhood
growth, and the pubertal height growth spurt.1 Genes are
estimated to account for up to 60%–80% of the within-
population variation of overall height growth.2,3 Although
the individual genes still remain largely unknown, epide-
miological studies propose partly overlapping genetic regu-
lation covering multiple aspects of growth. For example,
a longitudinal study of Swedish male twins suggested
that a large proportion of the genes affecting postnatal
growth in height are the same or are closely linked
throughout the whole growth period.3 Furthermore,
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The Ameaccount for the correlation between increased prepubertal
body mass index and the timing of pubertal growth and
maturation.4 Thus far, there have been no genome-wide
association studies (GWAS) speciﬁcally targeting child-
hood height growth, whereas there have beenmany recent
large-scale association studies successfully identifying loci
inﬂuencing both body size and pubertal timing. Although
there are as many as 47 veriﬁed hits inﬂuencing ﬁnal
stature,2,5 11 loci inﬂuencing adult body mass index,6–8
and 2 loci inﬂuencing age at menarche,9–12 these ﬁndings
explain only a marginal proportion of the overall variance
of each trait. Additionally, we know very little about how
these loci may inﬂuence longitudinal growth.
To elucidate the genetic framework inﬂuencing height
growth, we utilized the unique resource of longitudinal
childhood height data available in Finnish cohorts.13–19
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Figure 1. Study Populations and Design
Study samples:
Northern Finland Birth Cohort 1966 (NFBC1966) is a prospective cohort study conducted in the two northernmost provinces of
Finland, Oulu and Lapland, representing 96% of all births in these provinces.13,14 The offspring were followed up at 6 mos. and at 1,
14, and 31 yrs of age. Height at 14 yrs was obtained by self-report from questionnaires mailed to the adolescents. At age 31, a represen-
tative subsample of the study subjects (cohort members still living in Northern Finland or in the capital area) were invited for clinical
examination. At the clinical visit, the participants’ (n ¼ 5654) height and weight were assessed, and a blood sample was obtained, from
which DNAwas extracted. Extended data on height and weight from 1 to 12 yrs were retrospectively obtained from growth records orig-
inally collected by the school health care service and thereafter archived at communal health clinics. In case there were two height
measurements within 51 year of a speciﬁc birthday, the height at the birthday was extrapolated from the measurements, assuming
a linear relationship. For the remaining subjects, the corresponding height was evaluated by speciﬁc linear regression only if there
was one measurement within50.5 yrs of the birthday.
Cardiovascular Risk of Young Finns Study (YF) is a prospective cohort study conducted at ﬁve university departments of medical schools
in Finland (i.e., Turku, Helsinki, Kuopio, Tampere, andOulu), with the aim of studying the levels of cardiovascular risk factors in children
and adolescents in different parts of the country. The baseline study was conducted in 1980, and the study subjects were followed with
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for many reasons. Importantly, this growth phase regulates
ﬁnal height, accounting for as much as 15%–20% of adult
stature.20,21 Furthermore, most aspects of this growth
period are highly heritable.3,22,23 Finally, the phenotypic
variation is very large, with as much within-sex variation
in timing as 4 yrs.24 The design of our study is presented
in Figure 1. Altogether, three different Finnish population
cohorts with longitudinal height data collected at different
time points during childhood and adulthood, in addition
to a fourth cohort with data on adult height, were
included. A precise assessment of the pubertal growth
spurt requires very frequent height measurements span-
ning a large age range, data which typically are not readily
obtained in an epidemiological setting. Therefore, we
monitored this growth phase with a simple and robust
measurement capturing growth during late adolescence,
the increase in height between age 14 and adulthood.
This approach allowed us to maximize the number of
subjects available for genome-wide association mapping,
thereby also increasing the statistical power. A similar
measurement, i.e., the change in relative height between
age 12 and adulthood in females and between age 14 and
adulthood in males, has previously been shown to corre-
late strongly with the timing of the pubertal growth
spurt.25 Thus, our study design primarily facilitated the
detection of loci inﬂuencing the timing of the pubertal
growth spurt. Moreover, the availability of longitudinal
data on childhood height enabled the exploration of puta-
tive shared genetic effects inﬂuencing multiple periods of
postnatal height growth.
We ﬁrst performed GWAS analysis of height growth
during late adolescence in Northern Finland Birth Cohort
1966 (NFBC1966). The increase in height between age 14
and adulthood was used as an estimate of pubertal growth
in 2073 males and 2248 females with genotypes from Illu-
mina Inﬁnium 370CNV Duo arrays (Figure 1).26 Applying
previously established thresholds,26 ﬁve markers all
located in a single block of linkage disequilibrium (LD)
spanning 111 kb on chromosome 6q21, a block containing3 yr intervals until 1992; more recently in 2001, when blood samp
Height and weight were measured at each clinical visit. Adult stature
Helsinki Birth Cohort Study (HBCS) includes 8760 subjects born in
a representative subset of 928 males and 1075 females participated
outcomes and cognitive function. Height during childhood until age
and height at speciﬁc birth days was extracted as described by Eriksso
between ages 59 and 70.
Adult height was available in the Health 2000 study (H2000), whic
National Institute for Health and Welfare in Finland from fall 2000
individuals drawn from the Finnish population aged 18 and older. Th
tions, functional ability and limitations, determinants of health, and
sentative of the Finnish population over age 30, roughly 1000 non
criteria for metabolic syndrome and a control cohort of 1000 subject
yses. The age range was between ages 30 and 75. In the current stud
All cohort studies were approved by their corresponding local ethica
according to the approved protocols.
Study design: The primary GWAS analysis on height growth during
between age 14 and adulthood, and the replication analyses were car
the increase in height between age 15 and adulthood. Growth during
in height between ages 9 and 12 in YF and HBCS or as the increase in
and 15 in YF. Further follow-up studies of the entire growth trajecto
The Amethe 50 end and upstream region of LIN28B (MIM 611044)
(lin-28 homolog B [C. elegans]) and an uncharacterized
open reading frame c6orf220, yielded evidence for a signif-
icant association signal in the combined analysis of males
and females (p < 5 3 107). The signal predominantly
came from females and to a lesser extent also from males
(rs7759938; beta ¼ 0.159, standard error [SE] ¼ 0.032,
p ¼ 7.2 3 107 in females versus beta ¼ 0.093, SE ¼ 0.033,
p ¼ 0.005 in males; Table 1). Testing the best-associated
SNP (rs7759938) and a proxy (rs314268; beta ¼ 0.140,
SE ¼ 0.032, p ¼ 1.4 3 105 in females versus beta ¼ 0.095,
SE¼ 0.033, p¼ 0.004 in males) in the longitudinal replica-
tion cohort Cardiovascular Risk in Young Finns Study
(YF), including 1241 individuals (Figure 1), added further
support to the original observation (rs7759938, combined
p in all subjects ¼ 5.0 3 1011). The strongest associated
marker explained approximately 1% of the total pheno-
typic variation in females and roughly 0.5% in males, esti-
mated with the regression r2 in the Northern Finland Birth
Cohort Study with the normalized phenotype as the
outcome in an additive regression model adjusting for
the ﬁrst two dimensions obtained from the multidimen-
sional scaling analysis.27 Also, the genome-wide associa-
tion p values showed more apparent departure from the
quantile-quantile plot in females (see Figure S1 available
online). The reason for this phenomenon remains unclear.
Prior to regression analysis, the phenotypic outcome was
normalized and standardized, but the underlying raw
phenotype differed between males and females. The
average peak growth velocity occurs at approximately
12 yrs in females and 14 yrs in males. As a consequence,
the GWAS outcome captures growth a bit later relative to
the average peak growth velocity in girls than in boys.
Thus, the difference in association signals could in part
be a reﬂection that our measurement of growth during
late adolescence targets pubertal growth with a slightly
different focus and resolution in both sexes.
We hypothesized that the observed association might be
a consequence of an effect on the timing of the pubertalles for DNA extraction were drawn (n ¼ 2620); and in 2007.17,18
was measured between ages 24 and 42.
Helsinki between 1934 and 1944.15,16 Between 2000 and 2002,
in a clinical study focusing upon cardiovascular and metabolic
12 was obtained from child welfare and school health care records,
n et al.16 Adult stature was measured when the study subjects were
h was a health interview/examination survey carried out by the
to spring 2001, with a nationally representative sample of 10,000
e main topics of the study were health status, major chronic condi-
use of health care.19 From a subcohort of 6000 individuals repre-
diabetic subjects meeting the International Diabetes Federation
s matched for sex, age, and residence were selected for GWAS anal-
y, the data for two genotyped markers were used.
l committees, and the study subjects gave their informed consent
late adolescence (solid line) was analyzed based on height growth
ried out in YF via a similar estimate of pubertal height growth, i.e.,
early andmidadolescence (broken line) was assessed as the increase
height between ages 12 and 14 in NFBC1966 and between ages 12
ry from birth to age 12 were carried out in NFBC1966 and HBCS.
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Table 1. Association Signals between Pubertal Growth during Late Adolescence and LIN28B Obtained in Northern Finland Birth Cohort
1966 and the Replication Cohort Cardiovascular Risk of Young Finns Study
NFBC1966 Females YF Females
Chr. SNP Position n Beta (SE) p Value A1 MAF n Beta (SE) p Value MAF
6 rs10485311 105445489 2245 0.107 (0.058) 0.06334 G 0.07 - - - -
6 rs6923490 105455398 2247 0.083 (0.036) 0.02258 A 0.207 - - - -
6 rs4946651 105476203 2235 0.146 (0.03) 1.481 3 106 A 0.435 - - - -
6 rs7759938 105485647 2242 0.159 (0.032) 7.204 3 107 G 0.318 664 0.167 (0.058) 0.004311 0.33
6 rs314262 105501314 2200 0.15 (0.031) 9.103 3 107 G 0.44 - - - -
6 rs314280 105507530 2241 0.151 (0.03) 5.401 3 107 A 0.436 - - - -
6 rs12194974 105510891 2248 0.052 (0.051) 0.31 A 0.09 - - - -
6 rs314277 105514355 2214 0.126 (0.04) 0.001654 A 0.167 - - - -
6 rs314268 105524671 2240 0.14 (0.032) 1.422 3 105 G 0.32 666 0.135 (0.058) 0.01967 0.336
NFBC1966 Males YF Males
Chr. SNP Position n Beta (SE) p Value A1 MAF n Beta (SE) p Value MAF
6 rs10485311 105445489 2073 0.124 (0.058) 0.03156 G 0.076 - - - -
6 rs6923490 105455398 2072 0.04 (0.038) 0.3027 A 0.201 - - - -
6 rs4946651 105476203 2060 0.076 (0.031) 0.01611 A 0.436 - - - -
6 rs7759938 105485647 2068 0.093 (0.033) 0.004647 G 0.324 569 0.144 (0.066) 0.02969 0.308
6 rs314262 105501314 2019 0.082 (0.032) 0.009394 G 0.44 - - - -
6 rs314280 105507530 2066 0.072 (0.031) 0.02155 A 0.436 - - - -
6 rs12194974 105510891 2072 0.001 (0.058) 0.9874 A 0.084 - - - -
6 rs314277 105514355 2047 0.062 (0.041) 0.1263 A 0.174 - - - -
6 rs314268 105524671 2065 0.095 (0.033) 0.003559 G 0.329 570 0.121(0.066) 0.06681 0.315
Pubertal growth was estimated as height increase after age 14 (in NFBC1966) or age 15 (in YF). The data were analyzed by linear regression implemented in
PLINK27 covering the autosomes, assuming additive inheritance and including individual-specific scores of the first two dimensions of the multidimensional scaling
identical-by-state (IBS) analysis as covariates. The phenotype distribution for the increase in height between ages 14 and 31 was normalized by logarithm trans-
formation, and sex-specific Z scores computed from the normalized phenotype were used as input in the association analysis. The genomic inflation factor l was
1.04 in both sexes. The association results from males and females were combined into fixed-effect meta-analysis with reciprocal weighting on the square of stan-
dard errors of the effect size estimates via the MetABEL package for the R software. Positions are based on the NCBI B36 assembly. Abbreviations are as follows:
NFBC1966, Northern Finland Birth Cohort 1966; YF, Cardiovascular Risk in Young Finns Study; SE, standard error; MAF, minor allele frequency.growth spurt. Therefore, we conducted follow-up analyses
to characterize the growth effect at marker locus rs7759938
in more detail. Heights at ages 9, 12, and 15 were available
in YF, prompting analysis of the height increase between
ages 9 and 12 and between ages 12 and 14/15 to estimate
pubertal growth during early and midpuberty separately
in the subset of NFBC1966 study subjects with archived
growth charts available. Finally, we estimated growth
during early adolescence based on archived growth charts
in a third Finnish cohort, the Helsinki Birth Cohort Study
(HBCS) (Figure 1). The results are presented in Table S1.
Considering growth between ages 9 and 12 as a proxy for
the onset of the pubertal growth spurt, the observed corre-
lation between the G (ancestral) allele at rs7759938 and
decreased growth during early puberty both in males and
females (p ¼ 1.7 3 104) further supports an association
between the G allele and later timing of the pubertal
growth spurt.
Interestingly, the LIN28B region has previously been
associated with the timing of menarche in females.9–12776 The American Journal of Human Genetics 86, 773–782, May 14,Four independent studies reported signiﬁcant association
either with rs7759938, yielding the strongest evidence
for association in our study, or with markers in tight corre-
lation, the same alleles associating with later age of
menarche in other studies as with later timing of pubertal
growth here (Table S2; Figure S3). Marker rs7759938 was
also associated with age of menarche in the Finnish
cohorts (n ¼ 4379, beta ¼ 0.124, SE ¼ 0.023, p ¼ 8.3 3
108). Even though both the pubertal growth spurt and
menarche are secondary manifestations of pubertal matu-
ration, the growth spurt represents an early marker of
pubertal development in girls, whereas menarche is a late
event. To clarify the possible causal direction of the associ-
ations, we performed multiple regression analysis
including both rs7759938 and height growth during early
puberty (between ages 9 and 12) as a proxy for timing of
the pubertal growth spurt in the regression model. This
conditioned analysis resulted in a major reduction of the
association signal with age of menarche (beta ¼ 0.046,
SE ¼ 0.030, p ¼ 0.13, n ¼ 1932), suggesting that the effects2010
Table 2. Linear Regression Analysis of Final Height in Three Finnish Population Cohorts Evaluating the Effects of rs7759938 and rs314277
Regression of Single Markers Simultaneous Regression of Both Markers
rs7759938 rs314277 rs7759938 rs314277
NFBC1966 males 0.087 (0.030) 0.036 (0.037) 0.121 (0.041) 0.063 (0.050)
HBCS males 0.061 (0.057) 0.034 (0.077) 0.072 (0.072) 0.025 (0.097)
H2000 males 0.066 (0.048) 0.000 (0.062) 0.102 (0.060) 0.077 (0.077)
All males (beta [SE], p) 0.078 (0.023), p ¼ 8 3 104 0.028 (0.029), p ¼ 0.35 0.107 (0.031), p ¼ 5 3 104 0.061 (0.039), p ¼ 0.12
n 4211 4184 4176 4176
NFBC1966 females 0.062 (0.030) 0.089 (0.037) 0.028 (0.039) 0.0721 (0.048)
HBCS females 0.090 (0.051) 0.159 (0.065) 0.021 (0.067) 0.137 (0.086)
H2000 females 0.021 (0.047) 0.039 (0.059) 0.004 (0.059) 0.036 (0.076)
All females (beta [SE], p) 0.058 (0.023), p ¼ 0.01 0.091 (0.028), p ¼ 0.001 0.021 (0.029), p ¼ 0.48 0.075 (0.037), p ¼ 0.04
n 4692 4676 4645 4645
Females and males (beta [SE], p) 0.074 (0.017), p ¼ 3 3 105 0.062 (0.020), p ¼ 0.003 0.062 (0.021), p ¼ 0.003 0.011 (0.027), p ¼ 0.69
The study populations included in the analysis were Northern Finland Birth Cohort 1966 (NFBC1966), Helsinki Birth Cohort Study (HBCS), and Health 2000
(H2000). The regression analysis of single markers at LIN28B is shown on the left, and the multiple regression analysis including both markers at LIN28B simul-
taneously in the regression model is shown on the right. The effect alleles are G at rs7759938 and A at rs314277. The regression analyses were run with cohort-
and sex-specific Z scores as the independent variable. In H2000, adult height was adjusted for age, and the individual scores were obtained from the first two
dimensions of multidimensional scaling IBS analysis of genotypes generated with Illumina 610 Bead Chips. SE, standard error.on both the timing of the growth spurt and the timing of
menarchemight not be independent. Rather, the timing of
pubertal growth and age of menarche may be mediated
through a common underlying mechanism.
In addition to association with pubertal timing, the
LIN28B region also coincides with a previously veriﬁed
height locus.28,29 Contrary to the published association
ﬁndings with age of menarche, association to ﬁnal height
has been reported at two distinct marker loci that are only
partially correlated with each other (pairwise r2 ¼ 0.26), at
rs314277 with a p value of 1.1 3 108 in roughly 25,000
individuals28 and at rs314268 with a p value of 7.7 3 107
in 49,000 individuals.29 Marker rs314268 appears to over-
lap with the pubertal timing effect, showing strong correla-
tion with the pubertal timing-associated SNP rs7759938
(r2¼ 0.94; Figure S3). Thus, the effect on ﬁnal height could
be mediated through pubertal timing because individuals
maturing later, as a result of a delayed growth spurt and
an extended overall period of height growth, may grow
taller than their earlier-maturing peers.30,31 Also, the previ-
ously published association ﬁnding at rs314277 could
reﬂect the same underlying functional mutation, in spite
of the modest pairwise correlation between rs314277
and the pubertal timing-associated marker rs7759938
(r2¼ 0.29). Alternatively, rs314277might tag a second inde-
pendent effect inﬂuencing ﬁnal height.
To test for the presence of two separate height-regulating
effects at LIN28B, we analyzed ﬁnal stature in three Finnish
cohorts, both by considering the effect of the pubertal
timing-associated markers rs7759938 and rs314277 sepa-
rately and by including both markers simultaneously in
the regression model. Consistent with the previous studies
on adult height, we found the markers to be associatedThe Amewith adult stature when analyzed individually (n ¼ 8903
at rs7759938, n¼ 8860 at rs314277; Table 2). Separate eval-
uation of females and males showed that rs314277 ap-
peared to contribute to ﬁnal height more signiﬁcantly in
females, whereas the effect at rs7759938 was, if anything,
stronger in males. An analysis of rs314277 conditional on
rs7759938 showed opposite effects on height in males
and females, also suggestive of a sex-speciﬁc effect of this
SNP (Table2). To formally test for interactionbetweengeno-
types and sex, we performed multiple regression analysis,
including both of the SNPs, sex, and all of their possible
interactions in the model (Table 3), ﬁnding evidence for
sex-genotype interaction at rs314277 (p ¼ 0.005). The
data thus support two independent effects at LIN28B inﬂu-
encing ﬁnal height, one tagged by the pubertal timing-
associated markers and one tagged by rs314277.
Because the different phases of postnatal growth likely
share a signiﬁcant proportion of the regulating genes,3
we wanted to evaluate whether the speciﬁc height growth
effects at LIN28Bmay also inﬂuence height growth prior to
puberty by analyzing the effect of both LIN28B markers
simultaneously on the complete postnatal growth trajec-
tory at 1 yr intervals in two independent cohorts
(NFBC1966 and HBCS). We ﬁrst visualized the effects by
plotting the marker-speciﬁc betas and standard errors ob-
tained from the multiple regression analyses of height
throughout childhood, including both markers in the
regression model, as a line chart (Figure 2). The analyses
showed markedly different patterns of association with
height in both sexes.
Consistent with our previous analysis of growth during
early and late adolescence, the G allele at the pubertal
timing-associated marker rs7759938 was associated withrican Journal of Human Genetics 86, 773–782, May 14, 2010 777
Table 3. Multiple Regression Analysis of Adult Stature in Three
Finnish Cohorts Evaluating Marker-Marker and Marker-Sex
Interactions
Independent Variable Beta SE p Value
rs7759938 0.10523 0.02986 0.000427
rs314277 0.16806 0.07567 0.026377
SEX 0.65858 0.02893 <2 3 1016
rs7759938 3 rs314277
interaction
0.04167 0.04989 0.403553
rs7759938 3 SEX
interaction
0.07596 0.04143 0.066754
rs314277 3 SEX
interaction
0.29371 0.10412 0.004802
rs7759938 3 rs314277 3
SEX interaction
0.07654 0.06932 0.269571
The regression analysis was run with cohort-specific Z scores as the dependent
variable in Northern Finland Birth Cohort 1966, Helsinki Birth Cohort Study,
and Health 2000; n¼ 8821. Markers rs7759938 and rs314277 and sex, in addi-
tion to marker and sex interaction, were included in the regression model. In
H2000, adult height was adjusted for age, and the individual scores were
obtained from the first dimensions of multidimensional scaling IBS analysis of
genotypes generated with Illumina 610 Bead Chips prior to the multiple
regression analysis. The AA, AG, and GG genotypes at marker locus
rs7759938 were coded as 0, 1, and 2; the CC, CA, and AA genotypes at
rs314277 were coded as 0, 1, and 2; and male and female sex were coded
as 0 and 1.
Figure 2. Linear Regression Analysis of Postnatal Height
Evaluating the Independent Effects of rs7759938 and rs314277
The results of linear regression of standardized birth length, stan-
dardized height at 1 yr intervals between age 1 and 12, standard-
ized height at age 14, and adult stature in Northern Finland Birth
Cohort 1966 and Helsinki Birth Cohort Study at marker locus
rs7759938 are shown in the upper panel and at rs314277 are
shown in the lower panel. The sex-speciﬁc effect sizes and stan-
dard errors were calculated, including both rs7759938 and
rs314277 in the regression model. For clarity, only one-sided stan-
dard errors are shown. The nominal p values of the sex speciﬁc
effects are indicated in the ﬁgure as follows: #p < 0.1–0.05,
*p < 0.05–0.01, **p < 0.01. The effect alleles are G and A at
rs7759938 and rs314277, respectively. n at ages 0, 1, 2, 3, 4, 5, 6,
7, 8, 9, 10, 11, 12, and 14 and at adulthood equals 2315, 2199,
1925, 1590, 1356, 1335, 1702, 2254, 1855, 1744, 1767, 2153,
2127, 2042, and 3136 in males and 2638, 2537, 2176, 1852,
1630, 1577, 2010, 2 514, 2054, 1935, 2001, 2417, 2292, 2208,
and 3555 in females. Height data was available for both cohorts
up until age 12 and as an adult. Height at age 14 was available
only in NFBC1966. Birth length in both cohorts has been adjusted
for gestational age.a reduction of the effect on relative height after age 9, fol-
lowed by a signiﬁcant increase in the effect after ages 12
and 14 (Figure 2), whereas no such effect was seen at
rs314277. Analyzing growth after age 14, including both
rs7759938 and rs314277 in the regression model,
conﬁrmed that only rs7759938 inﬂuenced the timing of
the pubertal growth spurt in both sexes (females and
males combined rs7759938 beta ¼ 0.130, SE ¼ 0.030,
p ¼ 1.83 105 versus rs314277 beta ¼ 0.007, SE ¼ 0.037,
p ¼ 0.85). However, the independent effect of the pubertal
timing-associated marker appeared to not be restricted to
puberty alone. In females, rs7759938 was associated with
a distinct reduction of effect size already during prepu-
berty, between ages 6 and 9. In males, the effect sizes re-
mained stable up until age 10. Multiple regression analysis
of the change in relative height between ages 6 and 9
conﬁrmed a signiﬁcant female-speciﬁc effect (rs7759938
beta ¼ 0.214, SE ¼ 0.054, p ¼ 6.65 3 105 and
rs314277 beta ¼ 0.023, SE ¼ 0.135, p ¼ 0.87;
rs7759938 3 rs314277 interaction beta ¼ 0.145,
SE ¼ 0.093, p ¼ 0.122; Table S3). At the other height-asso-
ciated locus, rs314277, the A (derived) allele, previously
associated with increased adult stature, consistently
showed negative effect sizes throughout childhood and
adulthood in males, whereas the female analysis showed
an accumulating increase in effect sizes initiated already
during infancy and reaching suggestive p value levels of
0.01 at ages 9 and 10 (Figure 2). Analyzing both males and
females simultaneously also indicated suggestive evidence
for genotype-sex interaction at rs314277, with p values of
0.03 and 0.01 at ages 9 and 10, respectively (Figure 2).778 The American Journal of Human Genetics 86, 773–782, May 14,To further characterize the speciﬁc effects on height
growth, we also conducted multiple regression analyses
of the total magnitude of height growth during infancy,
childhood, and puberty. The analyses did not reveal any
statistically signiﬁcant associations (Table S4), even
though patterns consistent with the cross-sectional anal-
yses of height could be observed. For example, rs314277,
which associated signiﬁcantly with both childhood and
adult female stature, showed a positive correlation with2010
growth during all three periods of growth in females. Thus,
both our cross-sectional analyses of childhood height and
our follow-up analysis of height growth suggest distinct
effects on height growth prior to puberty. Whereas
rs7759938 is associated with more rapid changes in
growth, taking effect during a shorter period of time than
the age ranges covering the complete childhood or
pubertal growth periods, rs314277 appears to tag a more
slowly accumulating effect inﬂuencing height predomi-
nantly in females.
In light of our results, LIN28B emerges as an important
overall regulator of postnatal height growth. Our primary
genome-wide analysis identiﬁed signiﬁcant association
between the gene region and the timing of pubertal
growth. However, our follow-up analyses show that the
genetic effects are not restricted to puberty, even though
both the current and previous studies9–12 show a strong
inﬂuence on pubertal timing. Furthermore, even if ﬁnal
height and pubertal growth are well correlated with each
other, we found that LIN28B signiﬁcantly inﬂuences
height growth already during early childhood prior to
the initiation of pubertal development. Moreover, the
association with ﬁnal height was not affected by control-
ling for age at menarche in the multiple regression model,
neither at rs7759938 (n ¼ 4645, beta ¼ 0.02, SE ¼ 0.031)
nor at rs314277 (beta ¼ 0.081, SE ¼ 0.039). Even though
all of our study populations are Finnish, we have reason
to believe that our ﬁndings are also applicable to other
populations of European descent, because both markers
subjected to follow-up studies have similar allelic frequen-
cies in the Finnish cohorts as in other European popula-
tions. Overall, our study highlights the complex genetic
regulation underlying a multifactorial trait, which in this
case could be successfully dissected by sex-speciﬁc analyses
considering two partially correlated genetic effects. The
strong sex interaction observed in the current study might
in part explain why the previous large-scale association
studies of ﬁnal height detected only barely signiﬁcant or
suggestive association when analyzing both sexes
together.28,29 Sex-speciﬁc mechanisms certainly can be ex-
pected to mediate a noticeable inﬂuence on both height
growth and ﬁnal stature. Therefore, we anticipate that
future sex-stratiﬁed association analyses of these traits
will likely add to our understanding of the underlying
regulatory network.
Amajor strength of the current study is the rather unique
longitudinal height data available in multiple well-charac-
terized cohorts. This setup enabled the inspection of
multiple growth phases within the same individuals, even
though the speciﬁc time points of the individual height
measurements varied. All cohorts were Finnish, and they
represented different geographical parts of the country.
Testing for population stratiﬁcation within the GWAS
cohort showed no evidence for major substructure. Also,
the twomarkers analyzed showed similar allelic frequencies
across the country. Nevertheless, with respect to year of
birth, there was a substantial range, from the 1920s to theThe Ame1960s, a circumstancewhichmight impactboth thepattern
of height growth and the estimate of ﬁnal height. For
example, the environmental conditions inﬂuencing height
growth can be expected to vary signiﬁcantly between both
the earlier and the latter part of the 20th century, and also
between the southern industrialized part and the northern
rural parts of the country. Furthermore, estimating ﬁnal
height in elderly study subjects, e.g., above 60 yrs of age,
might be hampered by, for instance, changes in posture or
compression of the discs between the vertebrae. Despite
these factors, expected to increase randomerror, the genetic
effects inﬂuencing height growth and ﬁnal stature were
remarkably similar between cohorts. In particular, the sex-
speciﬁc effect inﬂuencing ﬁnal height at rs314277 was
almost identical in all cohorts, as were the effects on child-
hood growth (Table 2; Figure S4). The similarity of the asso-
ciation results among cohorts, in addition to the similarity
of the association patterns between childhood and adult-
hood, make it unlikely that the observed genetic associa-
tions are spurious. Given the varying environmental
factors, the consistency of the association results further
suggests that the genetic effects are rather pervasive even
though they explain only aminor proportion of the overall
phenotypic variation.
The markers subjected to follow-up analysis both had
genome-wide signiﬁcant (p < 5 3 108) prior evidence
for exerting an effect on height growth. Nevertheless,
multiple follow-up analyses were performed. Many of
these tests were not independent because of the strong
correlation between measurements of childhood height
at consecutive years. After applying a conservative Bonfer-
roni-corrected threshold, p ¼ 0.005, correcting for ten
independent sex-speciﬁc tests, the main ﬁndings of consis-
tent evidence across cohorts for two independent growth
effects with sex-speciﬁc action and for the inﬂuence on
height growth prior to puberty remain signiﬁcant.
However, in the exploratory analyses we also report results
with p < 0.05, although we realize that further evidence is
needed to evaluate which of these suggestive signals are
real. For example, the nominal evidence for association
with birth length at rs7759938 in females and males
(beta ¼ 0.058, SE ¼ 0.025, p ¼ 0.02) may support an effect
on fetal growth, an effect well in accordance with the
expression pattern of LIN28B,32 although we do not have
sufﬁcient power to further validate this putative effect in
the current study.
Three published genome-wide selection scans, which
used haplotype-based33,34 and allele frequency spectrum
statistics,35 report signals suggestive of selection in the
vicinity of LIN28B. Therefore, given a link between the
timing of puberty and reproduction, the locus could be
a candidate target for natural selection. In the presence
of positive selection, one haplotype pattern is rapidly
driven to high frequency, and typically the selected allele
is therefore surrounded by a much longer haplotype
stretch than the other alleles. At LIN28B, the derived allele
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both common and present on a long haplotype extending
toward the telomere over at least 100 kb (Figure S5). Visu-
alization of the haplotype variation by median-joining
network analysis36 of the HapMap3 data also showed
a network pattern consistent with positive selection of
haplotypes carrying the derived early pubertal timing-asso-
ciated allele A at rs7759938 (Figure S6). In contrast, the
formal tests of a selective sweep (the iHS and FST statistics)
indicated that the selection signal lies about 250 kb from
the SNPs with the strongest association to pubertal timing
(Figure S7). This might imply that the target of selection is
distinct from the effect inﬂuencing pubertal timing.
However, determining the precise target of selection
remains a challenge because the localization of an iHS
peak is inﬂuenced by several factors, including recombina-
tion rates and stochastic events. Also, our coalescent simu-
lations of positive selection of a single variant in the
middle of a genomic segment of 800 kb showed that the
peak of the iHS landscape might be located as much as
200 kb away from the best selected variant, even assuming
uniform recombination rates (data not shown; see Lappa-
lainen et al.34 for details of the simulations). Certainly
pubertal timing, being closely linked to reproduction, is
an intuitive candidate target for recent positive selection.
Recent studies have indeed suggested that the short stature
pygmy phenotype in part would be a by-product of selec-
tion for early reproduction.37,38 Nevertheless, further
studies are needed to fully characterize the role of selection
in the evolutionary history of the LIN28B region.
In conclusion, we provide compelling evidence that the
genomic region harboring LIN28B, recently associated
with adult stature and timing of menarche,9–12,28,29 regu-
lates multiple aspects of human postnatal growth, with
a particularly strong inﬂuence at puberty. Finding more
than one independent genetic variant in the region
tagging distinctive and sex-speciﬁc effects suggests that
LIN28B might be an important switch regulating critical
aspects of human growth and development. One of the
markers tagging the effects is located in the 50 upstream
region of LIN28B, whereas the other one is intronic. Yet
the causative variants are yet unknown, as are the molec-
ular mechanisms mediating the effects. LIN28B is a
homolog of a key regulator of developmental timing in
C. elegans,39 so the effect on pubertal timing could bemedi-
ated through a conserved pathway inﬂuencing a develop-
mental clock mechanism. Recently, LIN28B was shown
to inhibit miRNA let-7 biosynthesis, resulting in upregula-
tion of let-7 targets.32,39 Several let-7 targets have previ-
ously been associated with ﬁnal height.28 Thus, LIN28B
might inﬂuence height growth in part through altered
expression of let-7-regulated genes, although functional
studies are needed to validate this proposedmode of action.Supplemental Data
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